Thursday, 23 Jan 2020

You are here

Maternal RA Increases Offspring Risk of Autoimmune Disorders

A Danish population study suggests that fetal exposure to maternal rheumatoid arthritis (RA) results in an increased offspring risk of thyroid disease, epilepsy and RA, compared to children born to mothers without RA.

Researchers examined a possible association between maternal RA and 15 select chronic diseases in the offspring in a national cohort study using Danish health registries. They examined 2106 children born to RA women (exposed) between 1989 and 2013 and compared outcomes to 1,378,539 children born by women without RA (unexposed).

Exposure to maternal RA resulted in an increased offspring risk for:

  • Thyroid diseases (hazard ratio [HR] 2.19; 95% confidence interval [95% CI] 1.14–4.21)
  • Epilepsy (HR 1.61; 95% CI 1.16–2.25)
  • RA 2.89 (HR 95% CI 2.06–4.05).

Increased but not significant were the odds of developing anxiety, personality disorders and chronic lung disease, including asthma (HR range of 1.15–1.16).

This registry, population-based analysis suggests in utero exposure to maternal RA is associated with an increased risk of select autoimmune conditions, including RA.  While there was a nearly 2-3 fold risk of these autoimmune conditions the overall individual risk still remained quite low (RA exposed risk to offspring was 1.6% compared with 0.7% in unexposed).

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Low Risk of Inflammatory Arthritis in Hidradenitis Suppurativa Patients

JAMA Dermatology reports that after the onset and diagnosis of hidradenitis suppurativa (HS), such patients have a higher risk of certain forms inflammatory arthritis.

Best of 2019 - War on RA - Part 1: Walk on the Moon

It’s a great time to be a rheumatologist and to manage RA. But, if you keep doing what you’re doing, you’re going to keep getting what you’ve got.

Best of 2019 - War on RA - Part 3: Useless Drugs

We have options that are endless – we have 28 biologics in rheumatology; 19 approved for RA in the last 20 years, but 15 of these are me-too copies or biosimilars. We currently have 2 JAK inhibitors and may have 3 or 4 by year end. But what we really need is the right drug, at the right time, in the right patient – but how will we know.

Link Between Obstructive Lung Disease and Developing RA?

We all know that the microbiome in the gut may be very important for multiple immune diseases. However, new findings from the ACR, 2019 in Atlanta reinforce how important the interface is between the lungs and developing rheumatoid arthritis.

Smoking Cessation Lowers RA Disease Activity and CV Risks

A multinational cross-sectional cohort study suggests that smoking cessation in rheumatoid arthritis (RA) patients is associated with lower disease activity measures, improved lipid profiles and lower rates of cardiovascular (CV) events.